Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT00871169 |
Title | Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | New Mexico Cancer Care Alliance |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of New Mexico Cancer Center @ Lovelace Medical Center | Albuquerque | New Mexico | 87102 | United States | Details | |
Hematology Oncology Associates | Albuquerque | New Mexico | 87106 | United States | Details | |
Cancer Center at Presbyterian Hospital | Albuquerque | New Mexico | 87110 | United States | Details | |
University of New Mexico Cancer Center | Albuquerque | New Mexico | 87131-0001 | United States | Details | |
Memorial Medical Center- Cancer Center | Las Cruces | New Mexico | 88011 | United States | Details |